Statistics
Publications
1
Citations
90
H-Index
1
Active since
1991
Affiliations
Johnson & Johnson (United States)(Current)
Kenneth D. Krantz is an author at Johnson & Johnson (United States) specializing in placebo-controlled efficacy assessment, oncology pharmacotherapy, and combination chemotherapy.
Publications per year
1991–1991
1
1
Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
Robert Abels, Kay Larholt, Kenneth D. Krantz et al. · Stem Cells · 1991 · 90 citations
1–1 of 1